Situation: A 72-year-old woman with Parkinson disease for 9 years is admitted to the medical ward with community-acquired pneumonia. At home she takes carbidopa-levodopa 25/100 mg by mouth at 06:00, 10:00, 14:00, and 18:00. She has no drug allergies. On the second night she is restless and says she sees strangers in her room. The following as-needed (PRN) orders are on her chart. Which order should the nurse question?

Haloperidol and most first-generation antipsychotics block dopamine and can severely worsen rigidity and immobility in Parkinson disease. When an antipsychotic is needed, low-dose quetiapine, clozapine, or pimavanserin is used. The nurse also looks for a cause of the new confusion, such as her infection.

Why haloperidol is the order to question

Parkinson disease (PD) is defined by progressive loss of dopaminergic neurons in the substantia nigra. Carbidopa-levodopa works by replacing that missing dopamine. Haloperidol is a first-generation antipsychotic whose primary mechanism is potent blockade of dopamine D2 receptors. In a patient with PD, that blockade directly opposes levodopa therapy and can trigger a severe, sometimes life-threatening worsening of rigidity, bradykinesia, and immobility—including neuroleptic malignant syndrome in extreme cases ^[1]. This is why the nurse should question the haloperidol order before administration.

Most first-generation antipsychotics, including haloperidol, are contraindicated or strongly avoided in Parkinson disease because their dopamine blockade can acutely reverse motor control. The new-onset visual hallucinations and restlessness in this patient are consistent with Parkinson disease-related psychosis (PDP), which is common in advanced PD and is often precipitated or worsened by infection, dehydration, or medication changes ^[1]. Community-acquired pneumonia is a classic trigger.

Safer antipsychotic choices in Parkinson disease

When an antipsychotic is truly required for PDP, agents with minimal D2 blockade are preferred. The evidence base consistently supports quetiapine, clozapine, and the selective serotonin 5-HT2A inverse agonist pimavanserin as the mainstays ^[1]. Quetiapine has low affinity for D2 receptors, which explains why it is less likely to worsen motor symptoms, although its efficacy for psychosis is modest and sedation can occur ^[1]. Clozapine is effective but requires blood monitoring for agranulocytosis, which limits routine use ^[1]. Pimavanserin is approved specifically for PDP and does not block dopamine receptors at all ^[1].

Antipsychotic	Dopamine D2 blockade	Use in Parkinson disease psychosis
Haloperidol	High	Avoid; worsens rigidity and immobility
Quetiapine	Low	Commonly used off-label; low motor risk
Clozapine	Low	Effective; requires CBC monitoring
Pimavanserin	None (5-HT2A inverse agonist)	FDA-approved for PDP; no motor worsening

Watch out! The intramuscular route for haloperidol does not make it safer—the risk comes from the drug itself, not the route. An agitated older adult with PD who receives IM haloperidol may become profoundly rigid and unable to move within hours.

Why the other options are acceptable

Ondansetron 4 mg IV is a 5-HT3 antagonist used for nausea. It does not block dopamine D2 receptors, so it does not worsen parkinsonian motor symptoms ^[1]. It is a reasonable PRN order for nausea in this patient.

Quetiapine 12.5 mg orally at bedtime is a low dose and is the safest antipsychotic option among the choices for PDP. The low dose and oral route are appropriate for an older adult with new hallucinations ^[1].

Paracetamol 500 mg orally every 6 hours is a standard antipyretic for fever associated with pneumonia. It has no dopamine-blocking activity and does not interact with levodopa in a clinically significant way.

Clinical priority beyond the medication order

New confusion and visual hallucinations in a hospitalized patient with PD should never be attributed only to the disease. The nurse must first search for a reversible precipitant—infection, hypoxia, dehydration, electrolyte disturbance, urinary retention, or a newly added medication—before treating the psychosis itself. In this case, community-acquired pneumonia is the most likely trigger, and treating the infection is the primary intervention ^[1]. Non-pharmacologic measures such as a quiet room, reorientation, and adequate lighting are also first-line for PDP ^[1].

Key point! Haloperidol and other first-generation antipsychotics are high-risk in Parkinson disease because their D2 blockade directly opposes levodopa. Quetiapine, clozapine, or pimavanserin are the preferred agents when an antipsychotic is unavoidable ^[1].